• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

lev.kats@unimelb.edu.au

Credentials


Position
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0001-8742-8138

A/Prof Lev Kats

Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology

59 Scholarly works
4 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Abstract 4501: Targeting the epigenetic adaptor protein menin in multiple myeloma.
    DOI: 10.1158/1538-7445.am2026-4501
  • 2026

    Journal article

    Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity
    DOI: 10.1158/1535-7163.MCT-25-0306
  • 2026

    Journal article

    Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
    DOI: 10.1002/ijc.35426
  • 2026

    Journal article

    Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia
    DOI: 10.1016/j.cell.2025.10.028
  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Understanding and Targeting Self-Renewal in Aggressive Blood Cancers
  • 2022

    Journal article

    Non-genetic determinants of malignant clonal fitness at single-cell resolution
    DOI: 10.1038/s41586-021-04206-7
  • 2020

    Research Grant

    Rna Methylation in Normal and Malignant Blood Development
Lev Kats

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors
    DOI: 10.1038/s41467-025-59021-9
  • 2025

    Journal article

    2015 – MENIN ORCHESTRATES EXPRESSION OF THE MASTER PLASMA CELL TRANSCRIPTION FACTOR IRF4 AND IS AN ACTIONABLE TARGET IN MULTIPLE MYELOMA.
    DOI: 10.1016/j.exphem.2025.104928
  • 2025

    Journal article

    Building a transparent and functional laboratory culture: guidelines for creating a Laboratory Handbook for principal investigators
    DOI: 10.1016/j.exphem.2025.105265
  • 2025

    Journal article

    Advice for effective leadership and hitting the ground running as a new group leader
    DOI: 10.1016/j.exphem.2024.104674
  • 2024

    Journal article

    3099 – HEME BIOSYNTHESIS IS A THERAPEUTIC VULNERABILITY IN ACUTE MYELOID LEUKAEMIA
    DOI: 10.1016/j.exphem.2024.104421
  • 2024

    Journal article

    FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
    DOI: 10.1038/s41586-024-07242-1

RECENT PROJECTS

  • 2016

    Research Grant

    Understanding Response and Resistance to Inhibition of Mutant Isocitrate Dehydrogenase in Acute Myeloid Leukaemia
  • 2014

    Research Grant

    Exploring the Role of the Tumour Suppressor PML in Maintenance Of Leukaemia Initiating Cells

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224